Theratechnologies Inc. http://www.alacrastore.com/company-snapshot/Theratechnologies_Inc-2105444 Friday, January 09, 2009 5:56:58 AM 2105444 Theratechnologies Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/MW-0001-30516701newstex/MW-0001-30516701xml MONTREAL, CANADA, Dec. ##, #### (Marketwire delivered by Newstex) -- MONTREAL, CANADA -- (Marketwire) -- ##/##/## -- Theratechnologies (TSX: TH) announced today that it has closed its transaction related to the collaboration and licensing...0400000004002000040020060401600004016013070000000700100007001003070010070700100212/16/2008 1:21:06 PM180000001802200018015000190000001900200019002012MarketwireMW-0001-30516701MERCK & CO INCMERCK KGAATHERA TECHNOLOGIES INCMKGAYMRKTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/CCN-0001-30517619newstex/CCN-0001-30517619xml MONTREAL, CANADA, Dec. ##, #### (Marketwire delivered by Newstex) -- Theratechnologies (TSX:TH) announced today that it has closed its transaction related to the collaboration and licensing agreement with EMD Serono, Inc., an affiliate...0400000004002000040020060401600004016013070000000700100007001003070010020700100712/16/2008 1:20:52 PM180000001802200018015000Marketwire CanadaCCN-0001-30517619MERCK & CO INCMERCK KGAATHERA TECHNOLOGIES INCMKGAYMRKTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MW-0001-30479033newstex/MW-0001-30479033xml MONTREAL, QUEBEC, CANADA, Dec. ##, #### (Marketwire delivered by Newstex) -- MONTREAL, QUEBEC, CANADA -- (Marketwire) -- ##/##/## -- Theratechnologies (TSX: TH) announced today that the Hart-Scott Rodino Act waiting period has expired...04000000040020000400200607000000070010000700100312/15/2008 7:20:19 AM1800000018022000190000001900200019002012MarketwireMW-0001-30479033MERCK & CO INCMERCK KGAATHERA TECHNOLOGIES INCMKGAYMRKTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/CCN-0001-30479034newstex/CCN-0001-30479034xml MONTREAL, QUEBEC, CANADA, Dec. ##, #### (Marketwire delivered by Newstex) -- Theratechnologies (TSX:TH) announced today that the Hart-Scott Rodino Act waiting period has expired with respect to the collaboration and licensing agreement...04000000040020000400200607000000070010000700100312/15/2008 7:20:18 AM1800000018022000190000001900200019002012Marketwire CanadaCCN-0001-30479034MERCK & CO INCMERCK KGAATHERA TECHNOLOGIES INCMKGAYMRKTHNewsNewstexCANADA - Palo Alto Investors acquired a ##.##% stake, or #.### mil common shares, in Theratechnologies Inc, a biopharmaceutical company, in a privately negotiated transaction.12/12/2008 2:11:41 PM69743E88338H69743E88338HPalo Alto InvestorsTheratechnologies IncPalo Alto InvestorsTheratechnologies Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Palo_Alto_Investors_acquires_a_minority_stake_in_Theratechnologies_Inc-2034502040sdc/20345020402034502040Copyright © 2008, Thomson Financial, All Rights ReservedInvestment & Commodity Firms,Dealers,ExchangesUnited StatesInvestment advice6282CACaliforniaPrivate6282:Investment advice6722:Management investment offices, open-end6726:Investment offices, nec6799:Investors, nec6282:Investment advice6722:Management investment offices, open-end6726:Investment offices, nec6799:Investors, necTorontoDrugsCanadaBiological products, except diagnostic substances2836FFForeignPublicTH506971001Pvd invest,money mgmt svcsBiopharm coUnspecifiedCommon Stock259312001Dec 12 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.00000Palo Alto Investors, locatedin Palo Alto, California,provides investment and moneymanagement services toinstitutional clients and highnet worth individuals. Thecompany was founded in 1989.Palo Alto Investors, located in Palo Alto, California,provides investment and money management services toinstitutional clients and high net worth individuals. Thecompany was founded in 1989.Palo Alto Investors, located in Palo Alto, California, provides investment and money management services to institutional clients and high net worth individuals. The company was founded in 1989.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.0000020.00000Theratechnologies Inc, locatedin Quebec, Caanada, is aCanadian biopharmaceuticalcompany that discoversinnovative drug candidates inorder to develop them andbring them to market. TheCompany targets unmet medicalneeds in financiallyattractive specialty markets.Its most advanced program istesamorelin, now in aconfirmatory Phase 3 clinicaltrial for a serious metabolicdisorder known asHIV-associated lipodystrophy.The Company also has otherprojects at earlier stages ofdevelopment. The company wasfounded on 1993.Theratechnologies Inc, located in Quebec, Caanada, is aCanadian biopharmaceutical company that discovers innovativedrug candidates in order to develop them and bring them tomarket. The Company targets unmet medical needs infinancially attractive specialty markets. Its most advancedprogram is tesamorelin, now in a confirmatory Phase 3clinical trial for a serious metabolic disorder known asHIV-associated lipodystrophy. The Company also has otherprojects at earlier stages of development. The company wasfounded on 1993.Theratechnologies Inc, located in Quebec, Caanada, is a Canadian biopharmaceutical company that discovers innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets. Its most advanced program is tesamorelin, now in a confirmatory Phase 3 clinical trial for a serious metabolic disorder known as HIV-associated lipodystrophy. The Company also has other projects at earlier stages of development. The company was founded on 1993.0.000000.000000.0000058.15000Y10 Dec 08Wed, 10 Dec 2008 00:00:00 ESTDate Announced: 12/10/200810 Dec 08Date Effective: 12/10/200810 Dec 08Acq. Part. Int.Friendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.0000010.4800010.480000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.0000010.480000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.00000CANADA - Palo Alto Investorsacquired a 10.48% stake, or6.095 mil common shares, inTheratechnologies Inc, abiopharmaceutical company, ina privately negotiatedtransaction.CANADA - Palo Alto Investors acquired a 10.48% stake, or 6.095 mil common shares, in Theratechnologies Inc, a biopharmaceutical company, in a privately negotiated transaction.CANADA - Palo Alto Investors acquired a 10.48% stake, or 6.095 mil common shares, inTheratechnologies Inc, a biopharmaceutical company, in a privately negotiated transaction.CANADA - Palo Alto Investors acquired a 10.48% stake, or 6.095 mil common shares, in Theratechnologies Inc, a biopharmaceutical company, in a privately negotiated transaction.CANADA - Palo Alto Investors acquired a 10.48% stake, or 6.095 mil common shares, in Theratechnologies Inc, a biopharmaceutical company,in a privately negotiated transaction.Completed0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Completed-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002834:Pharmaceutical preparations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations506971001United States6282CaliforniaPrivate2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations259312001TorontoCanada2836ForeignPublicTH0.000000.000000.000000.00000Deal InformationTF Mergers & AcquisitionsCANADA - Merck KGAA agreed to acquire a #.#% stake, or #.### mil common shares, in Theratechnologies Inc, a biopharmaceutical company, for #.## Canadian dollars ($#.### US) per share, or a total value of C$#.### mil ($#.### mil), in a privately negotiated transaction.11/4/2008 3:35:20 PM58933988338H58933988338HMerck KGaATheratechnologies IncMerck KGaATheratechnologies Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/Merck_KGaA_acquires_a_minority_stake_in_Theratechnologies_Inc-2024522040sdc/20245220402024522040Copyright © 2008, Thomson Financial, All Rights ReservedFrankfurtDrugsGermanyPharmaceutical preparations2834FFForeignPublicMRK2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5122:Drugs, drug proprietaries, and druggists' sundries6719:Offices of holding companies, nec2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5122:Drugs, drug proprietaries, and druggists' sundries6719:Offices of holding companies, necTorontoDrugsCanadaBiological products, except diagnostic substances2836FFForeignPublicTH136805001Mnfr,whl pharmBiopharm coCashCash OnlyCommon Stock259312001Nov 4 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.00000Merck KGaA, located inDarmstadt, Germany,manufactures and wholesalespharmaceuticals, specialty andelectronic chemicals andcosmetic pigments. The companyalso serves as an investmentholding company. The companywas founded in 1668.Merck KGaA, located in Darmstadt, Germany, manufactures andwholesales pharmaceuticals, specialty and electronicchemicals and cosmetic pigments. The company also serves asan investment holding company. The company was founded in1668.Merck KGaA, located in Darmstadt, Germany, manufactures and wholesales pharmaceuticals, specialty and electronic chemicals and cosmetic pigments. The company also serves as an investment holding company. The company was founded in 1668.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.0000018.0000019.0000020.00000Theratechnologies Inc, locatedin Quebec, Caanada, is aCanadian biopharmaceuticalcompany that discoversinnovative drug candidates inorder to develop them andbring them to market. TheCompany targets unmet medicalneeds in financiallyattractive specialty markets.Its most advanced program istesamorelin, now in aconfirmatory Phase 3 clinicaltrial for a serious metabolicdisorder known asHIV-associated lipodystrophy.The Company also has otherprojects at earlier stages ofdevelopment. The company wasfounded on 1993.Theratechnologies Inc, located in Quebec, Caanada, is aCanadian biopharmaceutical company that discovers innovativedrug candidates in order to develop them and bring them tomarket. The Company targets unmet medical needs infinancially attractive specialty markets. Its most advancedprogram is tesamorelin, now in a confirmatory Phase 3clinical trial for a serious metabolic disorder known asHIV-associated lipodystrophy. The Company also has otherprojects at earlier stages of development. The company wasfounded on 1993.Theratechnologies Inc, located in Quebec, Caanada, is a Canadian biopharmaceutical company that discovers innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets. Its most advanced program is tesamorelin, now in a confirmatory Phase 3 clinical trial for a serious metabolic disorder known as HIV-associated lipodystrophy. The Company also has other projects at earlier stages of development. The company was founded on 1993.0.000000.000000.0000058.15000YCanadian Dollar29 Oct 08Wed, 29 Oct 2008 00:00:00 ESTDate Announced: 10/29/2008Date Effective:Acq. Part. Int.Friendly0.000000.000000.000000.000000.000004.73000Price/Share0.000009.902 Canadian Dollar9.90200275.068009.902 Canadian Dollar9.902000.000000.000003.876003.876009.902009.902 Canadian Dollar0.81900N4.949000.000000.000000.000000.000000.000008.114008.114000.000000.000000.000000.000000.000000.000000.000000.000003.600000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.00000CANADA - Merck KGAA agreed toacquire a 3.6% stake, or 2.094mil common shares, inTheratechnologies Inc, abiopharmaceutical company, for4.73 Canadian dollars ($3.876US) per share, or a totalvalue of C$9.902 mil ($8.114mil), in a privatelynegotiated transaction.CANADA - Merck KGAA agreed to acquire a 3.6% stake, or 2.094 mil common shares, in Theratechnologies Inc, a biopharmaceutical company, for 4.73 Canadian dollars ($3.876 US) per share, or a total value of C$9.902 mil ($8.114 mil), in a privately negotiated transaction.CANADA - Merck KGAA agreed to acquire a 3.6% stake, or 2.094 mil common shares, inTheratechnologies Inc, a biopharmaceutical company, for 4.73 Canadian dollars ($3.876 US)per share, or a total value of C$9.902 mil ($8.114 mil), in a privately negotiatedtransaction.CANADA - Merck KGAA agreed to acquire a 3.6% stake, or 2.094 mil common shares, in Theratechnologies Inc, a biopharmaceutical company, for 4.73 Canadian dollars ($3.876 US) per share, or a total valueof C$9.902 mil ($8.114 mil), in a privately negotiated transaction.CANADA - Merck KGAA agreed to acquire a 3.6% stake, or 2.094 mil common shares, in Theratechnologies Inc, a biopharmaceutical company,for 4.73 Canadian dollars ($3.876 US) per share, or a total value of C$9.902 mil ($8.114 mil), in a privately negotiated transaction.BMO Capital MarketsLazard1.000002.00000$ 8.114 - BMO Capital Markets - Adv$ 8.114 - Lazard - Adv0.000000.00000Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002834:Pharmaceutical preparations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations136805001FrankfurtGermany2834ForeignPublicMRK2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances8071:Medical laboratories8731:Commercial physical and biological research8733:Noncommercial research organizations259312001TorontoCanada2836ForeignPublicTH8.114009.902008.114004.94900Fasken Martineau DuMoulin LLPDeal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/newstex/PRN-0003-29050202newstex/PRN-0003-29050202xml GENEVA, Switzerland, Oct. ##, #### (PR Newswire Europe delivered by Newstex) -- v> - Merck Serono's US Affiliate EMD Serono, Inc. to Acquire Rights in Tesamorelin, a Phase # Compound Being Investigated for the Treatment of Excess...11000000110020000400000004002000040020060401600004016013040160080700000007001000070010030700100207001007070030000700300107014000070140120701401413000000130010001300100210/29/2008 10:23:40 AM180000001802200018007000180150001900000019001000190020001900200719002018PR Newswire EuropePRN-0003-29050202MERCK & CO INCMERCK KGAATHERA TECHNOLOGIES INCMKGAYMRKSEOTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-29048244newstex/PRN-0005-29048244xml Oct. ##, #### (PR Newswire delivered by Newstex) -- -- EMD Serono to acquire US rights in tesamorelin, a Phase III compound being investigated for the treatment of excess abdominal fat in HIV patients with lipodystrophy -- Theratechnologies...070000000700500009000000090150001100000011002000040000000400200004002006040160000401600804016013070010000700100307001002070010070700300007003001130000001301000013010005130010001300100210/29/2008 8:21:35 AM18000000180220001800700018015000PR Newswire USPRN-0005-29048244EMD Serono, Inc.MERCK & CO INCMERCK KGAATHERA TECHNOLOGIES INCMKGAYMRKTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MW-0001-29048260newstex/MW-0001-29048260xml MONTREAL, CANADA, Oct. ##, #### (Marketwire delivered by Newstex) -- MONTREAL, CANADA -- (Marketwire) -- ##/##/## -- Theratechnologies (TSX: TH) and EMD Serono Inc., an affiliate of Merck KGaA , Darmstadt Germany, today announced they...0700000007005000090000000901500004000000040020000400200604016000040160080401604807001000070010030700100207001007070030000700300113000000130100001301000510/29/2008 8:21:34 AM1800000018022000190000001900200019002012MarketwireMW-0001-29048260MERCK & CO INCMERCK KGAATHERA TECHNOLOGIES INCMKGAYMRKTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/CCN-0001-29048488newstex/CCN-0001-29048488xml MONTREAL, CANADA, Oct. ##, #### (Marketwire delivered by Newstex) -- Theratechnologies (TSX:TH) and EMD Serono Inc., an affiliate of Merck KGaA , Darmstadt Germany, today announced they have entered into a collaboration and licensing...0700000007005000090000000901500004000000040020000400200604016000040160080401604807001000070010030700100207001007070030000700300113000000130100001301000510/29/2008 8:21:33 AM1800000018022000Marketwire CanadaCCN-0001-29048488MERCK & CO INCMERCK KGAATHERA TECHNOLOGIES INCMKGAYMRKTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/CCN-0001-29043175newstex/CCN-0001-29043175xml MONTREAL, QUEBEC, Oct. ##, #### (Marketwire delivered by Newstex) -- Theratechnologies (TSX:TH) advises of an upcoming conference call and webcast to discuss the conclusion of the strategic review. The call will be moderated by Dr....04000000040020000400200604016000040160480401601810/28/2008 10:18:53 PM180000001800800018004000Marketwire CanadaCCN-0001-29043175THERA TECHNOLOGIES INCTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MW-0001-29043075newstex/MW-0001-29043075xml MONTREAL, QUEBEC, Oct. ##, #### (Marketwire delivered by Newstex) -- MONTREAL, QUEBEC -- (Marketwire) -- ##/##/## -- Theratechnologies (TSX: TH) advises of an upcoming conference call and webcast to discuss the conclusion of the strategic...04000000040020000400200604016000040160180401604810/28/2008 10:18:53 PM18000000180040001800800019000000190030001900200019002012MarketwireMW-0001-29043075THERA TECHNOLOGIES INCTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/CCN-0001-28637403newstex/CCN-0001-28637403xml MONTREAL, QUEBEC, Oct. #, #### (Marketwire delivered by Newstex) -- Theratechnologies (TSX:TH) today announced its financial results for the third quarter ended August ##, #### and reviewed recent corporate highlights of the quarter."During...0700000007005000070130000900000009015000040000000400200004002006040160000401604804016047040160180401600104016052040160030401600807001000070010030700100207001007070140000701400310/9/2008 3:24:14 PM180000001800800018004000180120001802000019000000190010001900200019002012Marketwire CanadaCCN-0001-28637403THERA TECHNOLOGIES INCTHNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/MW-0001-28637383newstex/MW-0001-28637383xml MONTREAL, QUEBEC, Oct. #, #### (Marketwire delivered by Newstex) -- MONTREAL, QUEBEC -- (Marketwire) -- ##/##/## -- Theratechnologies (TSX: TH) today announced its financial results for the third quarter ended August ##, #### and reviewed...0700000007005000070130000900000009015000040000000400200004002006040160000401604804016047040160180401600104016052040160030401600807001000070010030700100207001007070140000701400310/9/2008 2:24:14 PM180000001800800018004000180120001802000019000000190010001900200019002012MarketwireMW-0001-28637383THERA TECHNOLOGIES INCTHNewsNewstex